Gut microbiome and aging-related disorders: mechanistic insights and emerging microbiome-targeted therapies for healthy aging.
- 1Department of Food Science and Biotechnology, Gachon University, Seongnam, Republic of Korea.
- 2College of Korean Medicine, Gachon University, Seongnam, Republic of Korea.
Abstract
Background
The human gut harbors a diverse and dense microbial community that maintains metabolic, immune, and intestinal homeostasis through a symbiotic relationship with the host. Aging is a complex biological process that involves alterations in the gut microbiome, including decreased microbial diversity and a decline in beneficial microbiota that produce useful metabolites, which impair intestinal barrier function and enhance chronic low-grade inflammation (inflammaging).Scope
This review explores current evidence on the interaction between aging and the gut microbiome, emphasizing its impact on age-associated diseases, such as frailty and sarcopenia, cardiovascular issues, type 2 diabetes, obesity, osteoporosis, and neurodegenerative conditions. It further delves into the distinct microbial profiles of centenarians and evaluates microbiome-targeted interventions, such as dietary approaches, probiotics, prebiotics, synbiotics, fecal microbiota transplants, caloric restriction, intermittent fasting, and pharmaceutical agents, by synthesizing evidence from both human and animal research to emphasize their potential in fostering healthy aging and increased longevity.Key findings
Evidence from human and preclinical studies suggests that alterations in the gut microbiome associated with aging facilitate immune dysregulation, metabolic dysfunction, and the progression of various chronic diseases. Whereas, centenarians possess distinctive microbial signatures rich in beneficial metabolites that could promote healthy aging and prolonged life. Additionally, microbiome-targeted interventions have demonstrated promise in enhancing gut microbial diversity and host wellbeing, though their clinical effectiveness needs additional validation.Conclusion
The gut microbiome is a potential focus for supporting healthy aging and warding off age-related illnesses. Nonetheless, its significant inter-individual variability emphasizes the necessity for personalized microbiome-based approaches, which require validation through extensive longitudinal studies and properly structured randomized controlled trials to demonstrate causality and verify long-term effectiveness.
Related
- Metabolic reprogramming and metabolic homeostasis in podocyte injury: novel mechanistic insights and natural product therapies
- Emerging roles and mechanistic insights of ASRGL1 in tumorigenesis and cancer progression
- The Microbiota-Metabolism Axis: Mechanistic Insights and Translational Targets Across Diabetes and Gastrointestinal Disorders.
- Emerging Roles of tRNA-Derived Small RNAs in Cardiovascular Diseases: Mechanistic Insights and Translational Perspectives
- The gut microbiome and vascular disease — A systematic review of mechanistic insights and implications for vascular surgery
BibTeX
@article{islam2026microbiome,
title = {{Gut microbiome and aging-related disorders: mechanistic insights and emerging microbiome-targeted therapies for healthy aging.}},
author = {Md Minarul Islam and Gabsik Yang and Ki Sung Kang},
journal = {Frontiers in nutrition},
year = {2026},
month = oct,
doi = {10.3389/fnut.2026.1839461},
url = {https://europepmc.org/article/MED/43011890},
note = {CC BY},
}
RIS
TY - JOUR
TI - Gut microbiome and aging-related disorders: mechanistic insights and emerging microbiome-targeted therapies for healthy aging.
AU - Md Minarul Islam
AU - Gabsik Yang
AU - Ki Sung Kang
PY - 2026
DA - 2026/10/27
JO - Frontiers in nutrition
DO - 10.3389/fnut.2026.1839461
UR - https://europepmc.org/article/MED/43011890
AB - Background The human gut harbors a diverse and dense microbial community that maintains metabolic, immune, and intestinal homeostasis through a symbiotic relationship with the host. Aging is a complex biological process that involves alterations in the gut microbiome, including decreased microbial diversity and a decline in beneficial microbiota that produce useful metabolites, which impair intestinal barrier function and enhance chronic low-grade inflammation (inflammaging).Scope This review explores current evidence on the interaction between aging and the gut microbiome, emphasizing its impact on age-associated diseases, such as frailty and sarcopenia, cardiovascular issues, type 2 diabetes, obesity, osteoporosis, and neurodegenerative conditions. It further delves into the distinct microbial profiles of centenarians and evaluates microbiome-targeted interventions, such as dietary approaches, probiotics, prebiotics, synbiotics, fecal microbiota transplants, caloric restriction, intermittent fasting, and pharmaceutical agents, by synthesizing evidence from both human and animal research to emphasize their potential in fostering healthy aging and increased longevity.Key findings Evidence from human and preclinical studies suggests that alterations in the gut microbiome associated with aging facilitate immune dysregulation, metabolic dysfunction, and the progression of various chronic diseases. Whereas, centenarians possess distinctive microbial signatures rich in beneficial metabolites that could promote healthy aging and prolonged life. Additionally, microbiome-targeted interventions have demonstrated promise in enhancing gut microbial diversity and host wellbeing, though their clinical effectiveness needs additional validation.Conclusion The gut microbiome is a potential focus for supporting healthy aging and warding off age-related illnesses. Nonetheless, its significant inter-individual variability emphasizes the necessity for personalized microbiome-based approaches, which require validation through extensive longitudinal studies and properly structured randomized controlled trials to demonstrate causality and verify long-term effectiveness.
SN - 2296-861X
ER -